DK1268844T3 - Modulering af fremstilling af pneumococcus kapselformigt polysaccharid - Google Patents

Modulering af fremstilling af pneumococcus kapselformigt polysaccharid

Info

Publication number
DK1268844T3
DK1268844T3 DK01918754T DK01918754T DK1268844T3 DK 1268844 T3 DK1268844 T3 DK 1268844T3 DK 01918754 T DK01918754 T DK 01918754T DK 01918754 T DK01918754 T DK 01918754T DK 1268844 T3 DK1268844 T3 DK 1268844T3
Authority
DK
Denmark
Prior art keywords
modulation
preparation
capsular polysaccharide
test compound
pneumococcus
Prior art date
Application number
DK01918754T
Other languages
Danish (da)
English (en)
Inventor
Jeffrey N Weiser
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1268844(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Application granted granted Critical
Publication of DK1268844T3 publication Critical patent/DK1268844T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK01918754T 2000-03-16 2001-03-16 Modulering af fremstilling af pneumococcus kapselformigt polysaccharid DK1268844T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (fr) 2000-03-16 2001-03-16 Modulation de la production de polysaccharides capsulaires de pneumocoques

Publications (1)

Publication Number Publication Date
DK1268844T3 true DK1268844T3 (da) 2009-11-16

Family

ID=22699002

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01918754T DK1268844T3 (da) 2000-03-16 2001-03-16 Modulering af fremstilling af pneumococcus kapselformigt polysaccharid

Country Status (19)

Country Link
US (1) US6642017B2 (fr)
EP (2) EP1268844B1 (fr)
JP (1) JP4856345B2 (fr)
KR (3) KR100914702B1 (fr)
CN (2) CN100529054C (fr)
AT (1) ATE437955T1 (fr)
AU (2) AU4579501A (fr)
BR (1) BRPI0109293B8 (fr)
CA (1) CA2403001C (fr)
CY (1) CY1109418T1 (fr)
DE (1) DE60139384D1 (fr)
DK (1) DK1268844T3 (fr)
ES (1) ES2330919T3 (fr)
HK (1) HK1055448A1 (fr)
IL (3) IL151772A0 (fr)
MX (1) MXPA02009047A (fr)
NZ (1) NZ521343A (fr)
PT (1) PT1268844E (fr)
WO (1) WO2001068903A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100914702B1 (ko) * 2000-03-16 2009-08-28 더 칠드런스 호스피탈 오브 필라델피아 폐렴구균의 캡슐 다당류 생산의 조절 방법
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
PL1866342T3 (pl) * 2005-04-08 2019-04-30 Wyeth Llc Oddzielanie zanieczyszczeń od polisacharydu Streptococcus pneumoniae przez manipulację pH
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
CA2665169C (fr) * 2006-10-10 2017-02-21 Wyeth Purification de polysaccharides de streptococcus pneumoniae de type 3
WO2009059054A2 (fr) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Souches de bactéries et bactériocine produite à partir de celles-ci
PL2379734T3 (pl) * 2008-12-18 2018-08-31 Wyeth Llc Sposób kontrolowania masy cząsteczkowej polisacharydu serotypu 19A Streptococcus pneumoniae
PL2385981T3 (pl) * 2008-12-18 2020-01-31 Wyeth Llc Sposób kontroli masy cząsteczkowej polisacharydów streptococcus pneumoniae z zastosowaniem węgla
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
US9776905B2 (en) 2014-07-31 2017-10-03 Corning Incorporated Highly strengthened glass article
BE1022780B1 (fr) * 2014-05-07 2016-09-02 Glaxosmithkline Biologicals S.A. Purification des polysaccharides secretes par s. agalactiae
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
KR101952085B1 (ko) 2016-01-12 2019-05-21 코닝 인코포레이티드 얇은, 열적 및 화학적으로 강화된 유리-계 제품
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
WO2019040818A2 (fr) 2017-08-24 2019-02-28 Corning Incorporated Verres présentant des capacités de trempe améliorées
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
CN111630153A (zh) * 2018-01-22 2020-09-04 一般财团法人阪大微生物病研究会 用于培养肺炎球菌样品的培养基
KR20210154825A (ko) 2019-04-23 2021-12-21 코닝 인코포레이티드 확정 응력 프로파일을 갖는 유리 라미네이트 및 그 제조방법
CN114514115B (zh) 2019-08-06 2023-09-01 康宁股份有限公司 具有用于阻止裂纹的埋入式应力尖峰的玻璃层压体及其制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (fr) * 1993-04-20 1994-10-21 David E. Briles Regions epitopiques de la proteine pneumococcique de surface a
WO1995031548A1 (fr) * 1994-05-16 1995-11-23 The Uab Research Foundation Genes de polysaccharide capsulaire de streptococcus pneumoniaeet leurs regions d'encadrement
KR100914702B1 (ko) * 2000-03-16 2009-08-28 더 칠드런스 호스피탈 오브 필라델피아 폐렴구균의 캡슐 다당류 생산의 조절 방법

Also Published As

Publication number Publication date
US20030021811A1 (en) 2003-01-30
CY1109418T1 (el) 2014-08-13
EP1967591A3 (fr) 2008-12-03
PT1268844E (pt) 2009-11-03
WO2001068903A1 (fr) 2001-09-20
ES2330919T3 (es) 2009-12-17
ATE437955T1 (de) 2009-08-15
BR0109293A (pt) 2003-06-10
IL191962A (en) 2010-12-30
KR100942738B1 (ko) 2010-02-17
CA2403001A1 (fr) 2001-09-20
EP1268844A1 (fr) 2003-01-02
US6642017B2 (en) 2003-11-04
DE60139384D1 (de) 2009-09-10
EP1967591A2 (fr) 2008-09-10
NZ521343A (en) 2005-03-24
EP1268844B1 (fr) 2009-07-29
KR20080081978A (ko) 2008-09-10
JP2003531584A (ja) 2003-10-28
KR20080036656A (ko) 2008-04-28
MXPA02009047A (es) 2005-04-19
IL151772A (en) 2009-12-24
KR100914702B1 (ko) 2009-08-28
CN100529054C (zh) 2009-08-19
HK1055448A1 (en) 2004-01-09
IL191962A0 (en) 2008-12-29
CA2403001C (fr) 2012-07-03
EP1268844A4 (fr) 2006-03-29
CN1429276A (zh) 2003-07-09
BRPI0109293B8 (pt) 2021-05-25
AU2001245795B2 (en) 2005-07-28
CN101586143A (zh) 2009-11-25
JP4856345B2 (ja) 2012-01-18
BRPI0109293B1 (pt) 2015-05-19
IL151772A0 (en) 2003-04-10
AU4579501A (en) 2001-09-24
KR20030040196A (ko) 2003-05-22

Similar Documents

Publication Publication Date Title
DK1268844T3 (da) Modulering af fremstilling af pneumococcus kapselformigt polysaccharid
CY1117551T1 (el) Μεθοδος ελεγχου της δραστικοτητας ανοσολογικα λειτουργικου μοριου
ATE419005T1 (de) Staphylococcus aureus exopolysaccharid und verfahren
DE60144353D1 (de) Hybride Expression Neisserscher Proteine
TR200000338T2 (tr) Polietilen'in hazırlanmasına mahsus bir yöntem.
DE69919754D1 (de) Verwendung von aufgereinigtem invaplex als impfstoff für gram-negativebakterien
DE60122016D1 (de) Resorcinderivat für kautschukmassen
TR199800679T2 (xx) Kiral metil fenil oksazolidinon.
BG37376A3 (en) Method for preparing salts of benzothiazine dioxide
ATE445839T1 (de) Latentes tuberkulose-diagnostisches antigen und verwendungsmethode
NZ326675A (en) Oxazoline arthropodicides
EA200200435A1 (ru) Анализ лептина
TR200300942T1 (tr) Elektrikli süpürge
DK101196A (da) Histaminderivat, histamin-immunogen-konjugat samt antistof fremstillet mod konjugatet
DE69928888D1 (de) Reduziertes Cortisolkonjugat
DK0783520T3 (da) Bredt reaktive opsoniske antistoffer, som er reaktive mod fælles stafylokok-antigener
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
ATE420104T1 (de) Antigen
DE59913651D1 (de) Diagnostisches verfahren zur erkennung einer pankreasfunktionsstörung
DK0570682T3 (da) Syntetiske lipid-A-glycoconjugat-antigener til anvendelse i vacciner
DE60135552D1 (de) Selbstkonfigurierbare verstärkerschaltung
FR2778102B1 (fr) Utilisation d'oligomeres procyanidoliques (opc) ou d'anthocyanosides a titre d'agents anti-urease
ES1043546U (es) Junta vertical para bloques utilizables en fabrica armada.
KR950024113U (ko) 오픈탑형 큐에프피 핸들러용 소켓